Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-6 Blockade in Treated HIV Infection
NCT02049437Phase 2Completed
- Sponsor
- Case Western Reserve University
- Start
- Aug 2014
- Primary completion
- Sep 2017
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in human immunodeficiency virus infection (HIV), sponsored by Case Western Reserve University. Started Aug 2014; status: completed.
02
Drugs
tocilizumab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02049437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049437.